Ingredient Selection for "Anti-Fungal Foot Creams": The Compliance Boundaries of Tea Tree Oil / Piroctone Olamine

"Anti-fungal foot cream" sounds like a clear and direct product positioning—foot fungal infections (commonly known as athlete's foot) are one of the most universal foot concerns among global consumers, and market demand is undeniable.

But few brand owners realize that the four words "anti-fungal" themselves constitute a regulatory "red line." Once product claims involve terms like "anti-fungal," "treatment," or "eliminating infection," the product may inadvertently slip out of the "cosmetic" regulatory scope and into the "drug" or "OTC drug" regulatory scope. These two regulatory systems differ astronomically in approval requirements, time-to-market, and compliance costs.

Today, using the latest regulatory developments, we will thoroughly examine two common "antibacterial" ingredients—Tea Tree Oil and Piroctone Olamine—within the compliance framework.

I. Clarifying the Concepts: The Fundamental Boundary Between "Cosmetic Claims" and "Drug Claims"

The prerequisite for understanding all subsequent content is understanding the regulatory dividing line itself.

According to the US Federal Food, Drug, and Cosmetic Act (FD&C Act), cosmetic products and ingredients (except color additives) do not require FDA pre-market approval; whereas drugs typically must obtain pre-market approval through the FDA New Drug Application (NDA) process, or meet the "monograph" requirements established by the FDA OTC Drug Review. These monographs explicitly define the conditions under which OTC drug ingredients can be recognized as "Generally Recognized As Safe and Effective" (GRASE) and do not constitute misbranding.

This means that the efficacy claim of "anti-fungal" essentially falls into the category of treating diseases or altering the structure or function of the body—which is the core definitional boundary of drug regulation. Once a product crosses this line with its claims, it is no longer a simple cosmetic notification issue but requires following a specialized drug approval pathway.

II. Tea Tree Oil: The Brand-New Concentration Limits Introduced by the EU in 2025 Completely Change the Game

Tea Tree Oil (TTO) has long been regarded as the "standard ingredient" for natural antibacterial foot care products, but a series of regulatory developments in 2025 are drastically tightening its compliant usage space.

The final opinion (SCCS/1681/25) of the Scientific Committee on Consumer Safety (SCCS), adopted on October 30, 2025, and officially published on November 14, 2025, explicitly stipulates that when Tea Tree Oil is used as an anti-seborrheic and antimicrobial agent, the maximum safe use concentrations in four product types are: 2.0% for shampoos, 1.0% for shower gels, 1.0% for face cleansers, and 0.1% for face creams.

Please pay special attention to the last item—the concentration limit for face cream products is only 0.1%. This restriction poses a direct compliance impact on the large number of "high-concentration Tea Tree Oil foot cream" products on the market. Although this opinion specifically targets face creams, the concentration review logic and safety assessment framework it establishes have important reference significance and potential regulatory extension risks for leave-on products of the same category, such as body lotions and foot creams.

This SCCS opinion specifically points out that it only applies to Tea Tree Oil that meets the chemical composition requirements of the latest international standard (ISO 4730:2017), and is strictly limited to final percutaneous cosmetic products for adult use, and does not apply to aerosol or spray formulations. The committee also emphasized that, based on existing data, Tea Tree Oil is a moderate skin sensitizer, and its stability in the final product must be guaranteed.

Even more noteworthy is the risk assessment motivation behind it: The SCCS also highlighted the lack of stability data for Tea Tree Oil, pointing out that the oil is highly sensitive to degradation by light, heat, air, and humidity. The committee emphasized that the final formulation must maintain the chemical composition of Tea Tree Oil within the limits defined by the ISO standard, and specifically mentioned the upcoming ISO 4730:2025 revision, which will further regulate its optical isomer parameters. One of the committee's initial concerns was that Tea Tree Oil contains acetophenone—a compound naturally present in various essential oils and plant extracts, meeting the definition criteria for Natural Complex Substances (NCS).

This final opinion has a direct compliance enforcement impact on the cosmetic industry—manufacturers must take the following actions: formulation review; enterprises must audit all existing products containing Tea Tree Oil to verify whether the concentrations meet the new limit requirements; products exceeding this limit will need to be reformulated.

Direct implications for foot cream formulation design: If the product is positioned as a leave-on foot care product (not rinsed off after application), even if it does not directly benchmark the 0.1% limit exclusive to face creams, formulators should be highly alert to the concentration design of Tea Tree Oil and proactively track whether the EU will subsequently issue more explicit limit regulations for leave-on body care products. For foot cream products exported to the EU market, it is recommended to strictly control the Tea Tree Oil concentration within a safety range significantly lower than traditional formulation habits (some commercial products have concentrations as high as several percentage points).

III. Piroctone Olamine: Precise Positioning but Also Subject to "Claim Red Lines"

Piroctone Olamine (trade name Octopirox®) is another widely used ingredient in antibacterial/anti-fungal formulations. Its compliance pathway differs from Tea Tree Oil but also has insurmountable boundaries.

Piroctone Olamine is usually described as an anti-fungal active ingredient related to inhibiting scalp microorganisms, especially targeting the Malassezia genus fungi associated with dandruff and seborrheic dermatitis. The proposed mechanisms of action in the literature include: inhibiting ergosterol synthesis, or penetrating the fungal cell membrane to chelate iron ions, thereby interfering with mitochondrial energy metabolism—but its exact mechanism of action has not been fully elucidated.

Under the EU regulatory framework, Piroctone Olamine is listed in Annex V of the EU Cosmetics Regulation (EC No 1223/2009) as an allowed preservative, with a maximum concentration of 1.0% in rinse-off products and 0.5% in other products (leave-on).

This compliance positioning is crucial—under the EU regulatory system, Piroctone Olamine is permitted to be used as a "preservative," not as a pharmaceutical active ingredient that can claim to "treat fungal infections." This means that even if this ingredient is described in scientific literature as possessing anti-fungal activity, brand owners must still be cautious with their wording at the product claim level, avoiding expressions that imply "treatment" or "eliminating infection," otherwise they face the same risk of slipping from the cosmetic regulatory scope into the drug regulatory scope.

In the US market, the FDA once initiated a data collection procedure for Piroctone Olamine as an OTC anti-dandruff active ingredient, evaluating its safety and efficacy in leave-on products at concentrations of 0.05%~0.5% and rinse-off products at 0.1%~1.0%. This historical process indicates that if Piroctone Olamine is to obtain OTC drug status for specific efficacy claims like "dandruff control" in the US market, it must follow a specialized drug monograph approval pathway, rather than a simple cosmetic notification process.

It is worth noting that since the EU banned zinc pyrithione for use in cosmetics, Piroctone Olamine, climbazole, and salicylic acid have become the most commonly used anti-dandruff active ingredients in cosmetics. This industry landscape change indirectly illustrates the market recognition of Piroctone Olamine's "gentle, compliant antibacterial positioning."

Additionally, formulators need to pay attention to a frequently overlooked technical detail: Piroctone Olamine is photounstable, which can cause the product to gradually turn yellow under light exposure. This stability issue must be resolved in the formulation by adding benzaldehyde-type or alkylene glycol/triol stabilizers.

IV. Key Compliance Strategies: How to Find a Safe Zone Between "Efficacy" and "Claims"?

Understanding the regulatory landscape above, brand owners developing foot care products can follow these compliance strategies to pursue efficacy while avoiding regulatory risks:

Strategy 1: Use "Maintenance" Wording Instead of "Treatment" Wording

Avoid using terms with clear medical implications such as "anti-fungal," "treating athlete's foot," or "eliminating infection." Instead, adopt expressions more aligned with cosmetic positioning, such as "maintaining foot freshness," "soothing discomfort," or "cleanse formulation with Tea Tree Oil." This wording adjustment retains the product's core selling points while keeping the product firmly within the cosmetic regulatory framework, avoiding unnecessary compliance risks.

Strategy 2: Strictly Adhere to the Concentration Limits of Each Ingredient and Proactively Leave a Safety Redundancy

Based on the SCCS's latest limit opinion on Tea Tree Oil and the current concentration regulations for Piroctone Olamine, it is recommended that during the formulation design phase, not only the minimum compliance requirements are met, but a certain safety redundancy space is proactively left—especially considering the regulatory committee's explicit pointing out of the "lack of stability data" for Tea Tree Oil. The formulation should simultaneously adopt protective measures in concentration design and packaging selection (light-blocking packaging).

Strategy 3: Establish an Ingredient Stability Verification System

Based on the high sensitivity of Tea Tree Oil to light, heat, air, and humidity, and the photounstability of Piroctone Olamine, it is recommended that the OEM conduct dedicated accelerated stability testing for these two types of ingredients during the product R&D phase. This verifies whether the concentration and chemical composition of the active ingredients can be stably maintained within the compliance limits during the expected shelf life, rather than just passing a one-time inspection at the time of ex-factory.

Strategy 4: Pay Attention to the Dynamic Updates of ISO Standards

All Tea Tree Oil raw materials must comply with the latest international standard ISO 4730:2017, which defines the chemical composition specifications for Melaleuca alternifolia oil; and the newly released ISO 4730:2025 revision proposes updated requirements for the optical isomer parameters of the raw material. It is recommended that OEMs proactively verify whether the COA of Tea Tree Oil raw materials provided by suppliers meets the latest ISO standards during the raw material procurement stage, rather than relying on outdated testing criteria.

Are you looking for a reliable Skincare factory?

Are you seeking a trusted partner to launch or scale your skin care line? At Deva Skincare,we specialize in developing safe formulations that combine barrier science with clean, compliant manufacturing.

Our R&D team and certified production facilities deliver turnkey OEM/ODM solutions tailored to your target market’s regulatory and consumer expectations.

By collaborating with Deva Skincare, you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Contact us today to discover how we can help you succeed.

Anti-Fungal Foot Cream Final Thoughts: The Compliance Boundary is the Most Easily Overlooked "Hidden Cost" in Foot Care Products

The seemingly simple product positioning of "anti-fungal foot cream" involves a compliance complexity far beyond the expectations of most brand owners.

The newly introduced concentration limits for Tea Tree Oil in 2025, the identity definition of Piroctone Olamine between preservatives and anti-fungal active ingredients, and the invisible yet extremely critical red line between cosmetic and drug claims—every link could become a "hidden landmine" on the road to product export.

A truly responsible contract manufacturer will not simply accept a client's request to "make an anti-fungal foot cream" at face value, but will proactively point out the compliance risks and provide solutions that meet the product's efficacy positioning while remaining robustly within the compliance framework.

If you are developing a foot care product headlined by antibacterial and freshness efficacy, we welcome you to communicate with our R&D and compliance teams. Based on the latest regulatory dynamics, we will help you find the truly safe and persuasive balance point between efficacy claims and compliance boundaries. Deva Skincare